Efficacy Study of Liraglutide vs.Sitagliptin vs. Glargine on Liver Fat in T2DM Subjects

NCT02147925 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

75

Enrollment

OTHER

Sponsor class

Conditions

Non-alcoholic Fatty Liver Disease

Interventions

DRUG: Liraglutide combined with metformin
DRUG: Insulin glargine combined with metformin
DRUG: Sitagliptin combined with metformin

Sponsor

Sun Yat-sen University